1. Home
  2. ALMR vs HSAI Comparison

ALMR vs HSAI Comparison

Compare ALMR & HSAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alamar Biosciences Inc. Common Stock

ALMR

Alamar Biosciences Inc. Common Stock

N/A

Current Price

$38.23

Market Cap

2.1B

Sector

Industrials

ML Signal

N/A

Logo Hesai Group each ADS represents one Class B ordinary share

HSAI

Hesai Group each ADS represents one Class B ordinary share

SELL

Current Price

$16.01

Market Cap

2.4B

Sector

N/A

ML Signal

SELL

Company Overview

Basic Information
Metric
ALMR
HSAI
Founded
2018
2014
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.4B
IPO Year
2026
2021

Fundamental Metrics

Financial Performance
Metric
ALMR
HSAI
Price
$38.23
$16.01
Analyst Decision
Buy
Strong Buy
Analyst Count
5
20
Target Price
★ $35.40
$28.35
AVG Volume (30 Days)
460.6K
★ 925.6K
Earning Date
11-23-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
$59.79
$41.85
Revenue Next Year
$39.75
$41.41
P/E Ratio
★ N/A
$61.18
Revenue Growth
N/A
N/A
52 Week Low
$21.58
$14.29
52 Week High
$38.54
$29.35

Technical Indicators

Market Signals
Indicator
ALMR
HSAI
Relative Strength Index (RSI) 66.64 42.79
Support Level $23.69 $15.81
Resistance Level $38.15 $19.29
Average True Range (ATR) 2.51 0.47
MACD 0.38 -0.09
Stochastic Oscillator 94.11 30.88

Price Performance

Historical Comparison
ALMR
HSAI

About ALMR Alamar Biosciences Inc. Common Stock

Alamar Biosciences Inc is a proteomics company engaged in protein detection and analysis. The company has developed its own NULISA (NUcleic Acid Linked Immuno-Sandwich Assay) technology as the foundation of its Precision Proteomics platform enabling the detection and quantification of protein biomarkers in a single sample with ultra-high sensitivity and high specificity, even from very small volumes of biofluid. The company operates in single segment and focuses on developing a good sensitive proteomic liquid biopsy platform and sells instruments, consumables, and services based on this platform to enable early detection of diseases. The products of the company includes NULISAseq Panels, NULISAqpcr Assays, and others.

About HSAI Hesai Group each ADS represents one Class B ordinary share

Hesai Group is engaged in the development, manufacture, and sales of three-dimensional light detection and ranging solutions, or LiDAR. Its LiDAR products enable a broad spectrum of applications across passenger or commercial vehicles with enhanced driver assistance systems, or ADAS, autonomous vehicle fleets providing passenger and freight mobility services, or Autonomous Mobility, and other applications such as last-mile delivery robots, street sweeping robots, and logistics robots in restricted areas, or Robotics. Geographically, the company operates in North America, Mainland China, Europe, and Other regions.

Share on Social Networks: